Loading
Cardiovascular Disease and Adiposity / Adipokines, Inflammation, and Metabolic Diseases · Journal article
Current Obesity Reports · September 10, 2026
A consensus or society position rather than new primary data.
This is a narrative review synthesizing current understanding of how incretin-based therapies and bariatric surgery remodel adipose tissue in obesity beyond weight loss alone. The review identifies inflammatory, mitochondrial, and endocrine pathway changes across both subcutaneous and visceral depots, but acknowledges that mechanistic evidence in humans remains heterogeneous and limited by tissue accessibility.
Narrative review. Individuals with obesity undergoing incretin-based pharmacotherapy or bariatric surgery; reviewed studies include both animal models and human studies..
Obesity-induced adipose tissue remodeling is characterized by structural changes, extracellular matrix remodeling, altered endocrine signaling, and impaired mitochondrial function. Weight-loss interventions including incretin-based therapies and bariatric surgery are associated with improvements in adiposity and metabolic outcomes. Multiple studies suggest accompanying changes in inflammatory, mitochondrial/thermogenic, and endocrine pathways within white adipose tissue following these interventions.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should recognize that incretin-based therapies and bariatric surgery may improve metabolic health through adipose tissue remodeling mechanisms beyond weight loss; however, current human evidence for specific cellular mechanisms remains incomplete and warrants further targeted research before tissue-level mechanisms can guide clinical decision-making.
A narrative review synthesizing animal and human evidence on adipose tissue mechanisms in obesity treatment; establishes current understanding and identifies evidence gaps rather than presenting original data or a definitive clinical trial result.
As stated by the source record.
Clinicians should recognize that incretin-based therapies and bariatric surgery may improve metabolic health through adipose tissue remodeling mechanisms beyond weight loss; however, current human evidence for specific cellular mechanisms remains incomplete and warrants further targeted research before tissue-level mechanisms can guide clinical decision-making.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Abstract Purpose of the Review This review summarizes obesity-induced adaptations in subcutaneous and visceral white adipose tissue (WAT) depots and discusses how incretin-based pharmacotherapies and bariatric surgery may influence WAT remodeling beyond weight loss, drawing on evidence from animal models and human studies. Recent Findings In obesity, adipose tissue undergoes pathological remodeling characterized by structural and cellular changes, extracellular matrix (ECM) remodeling, altered endocrine signaling, and impaired mitochondrial function that contribute to metabolic comorbidities. Weight-loss interventions, including incretin-based therapies and bariatric surgery, are associated with improvements in adiposity and metabolic outcomes, and multiple studies suggest accompanying changes in inflammatory, mitochondrial/thermogenic, and endocrine pathways within WAT; however, mechanistic evidence in humans remains heterogeneous and is often limited by tissue accessibility and study design. Summary This review highlights candidate cellular and molecular mechanisms through which incretin-based pharmacotherapies and bariatric surgery may modulate WAT plasticity, emphasizing convergent and distinct effects across depots and the need for more longitudinal, tissue-level human studies to define weight-dependent remodeling versus changes not fully explained by weight loss.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.